12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Addex preclinical data

In a rat model of AD, mGluR2 NAM dose-dependently and significantly reversed memory deficit from baseline vs. vehicle-treated controls (p<0.05). Addex said...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >